The European Patent Office published patent EP4406569A2 for an aspiration and injection device filed by Allergan, Inc. The patent application was published on March 25, 2026, with international classifications in A61M covering injection and infusion systems. The designated states include all EU member states plus several additional European countries.

This is a routine patent publication that grants intellectual property protection to Allergan for their medical device technology. No compliance actions or regulatory responses are required from market participants. Healthcare providers and medical device manufacturers should note the intellectual property scope when developing similar aspiration or injection technologies to avoid potential infringement issues.